...
首页> 外文期刊>Breast cancer >Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries
【24h】

Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries

机译:在<斜体> BRCA1 / 2 /斜体>载体的组织基因组学随访,携带预防性手术的载体

获取原文

摘要

Purpose The genomic status of non-malignant tissues from carriers of pathogenic germline BRCA1/2 (g BRCA1/2 ) variants may reveal information towards individualized prophylaxis. We performed spatiotemporal tissue genotype comparisons in a real-life cohort of g BRCA1/2 carriers of Greek origin, who underwent multiple risk-reducing/prophylactic surgeries at various time points. Methods Fifty-three women (median age 36 years) within cancer families were observed for up to 37.5?years; 43 were cancer carriers and 10 were healthy carriers. Histology review and genotyping were performed for 187 paraffin tissues (average: 3.5 per carrier) including 46 carcinomas (40 breast) and 141 non-malignant breast and gynecological samples. Results High allelic imbalance (AI) and somatic pathogenic TP53 variants were present in cancer carriers only ( p values?
机译:目的,来自致病种类BRCA1 / 2(G BRCA1 / 2)变体(G BRCA1 / 2)变体的载体的非恶性组织的基因组状态可以揭示对个体化预防的信息。我们在希腊源的G BRCA1 / 2载体的现实生活队列中进行了时尚组织基因型比较,在各个时间点接受了多种风险降低/预防性手术的载体。方法癌症家庭中的五十三名女性(36岁)最多可观察到37.5岁;年份; 43是癌症载体,10是健康的载体。组织学审查和基因分型对187个石蜡组织(平均:3.5每个载体)进行,包括46个癌(40乳腺)和141个非恶性乳房和妇科样品。结果癌载体中存在高位等位基因不平衡(AI)和体细胞病原体TP53变体(P值?<?0.0001)。高AI与G BRCA1 / 2诱导有关(P?<β01)和G BRCA2改变(P?= 0.0109)。在非恶性组织和匹配的癌之间,体细胞(致病)变体很少共享。在来自癌症载体的组织中注意到G BRCA1变体杂合子的像差(13/43,30.2%)。这些与经典LOH(9/43载体中的肿瘤病变,20.9%)和种系变体的低于表示(5个样品,4个非恶性,乳房)。两种像差在一个案例中在匹配的样品中共存。随着时间的推移,非恶性组织中的种系变体杂合性普遍存在;载体内基因组改变加剧(21.1%),改善(26.3%)或保持稳定。结论这种现实生活案例研究支持从预防性手术中与朝向个性化预防的多基因分数与预防性手术的组织基因型进行地处理组织基因型。为此,了解G BRCA1 / 2变体的传统分类致病潜力可能不够。

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号